• Sanhita Sinharay will present in vivo catalyCEST MRI research at 2015 WMIC

    July 25, 2015

    Sanhita Sinharay has been selected to present an oral presentation at the 2015 World Molecular Imaging Congress, Sep. 2-5, 2015, in Honolulu, HI. She will present on “Pre-screening candidates for Optical Surgical Navigation by detecting GGT enzyme activity with catalyCEST MRI”. Sanhita is completing the final year of her Ph.D. studies in the Department of Chemistry and Biochemistry at the University of Arizona.

    Enzymes are significant biomarkers of cancer, hence elucidation of enzyme activity is important. Ovarian cancer is known... Read More

  • CAMEL Group receives third concurrent NIH R01 grant

    June 27, 2015

    The National Institute for Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health (NIH) has recently awarded a R01 grant to Dr. Marty Pagel and the CAMEL group.  This grant will support a clinical trial that will translate the acidoCEST MRI method to the radiology clinic, which will be used to measure tumor acidosis in patients with breast cancer.  Drs. Pavani Chalasani, Phil Kuo, Amanda Baker, Julio Cárdenas Rodríguez, and Ed Randtke are collaborating with Dr. Pagel and other CAMELs to perform this clinical translational study.... Read More

  • Gaby Fernandez-Cuervo awarded prestigious HHMI fellowship

    June 22, 2015

    Gabriela Fernandez-Cuervo has been awarded a Howard Hughes Medical Institute Gilliam Fellowship for Advanced Study, one of 30 fellowships awarded to outstanding students who are pursuing a Ph.D. degree in the life sciences and who are committed to increasing diversity among scientists. The award provides full support to promising students pursuing doctoral degrees in the life and biomedical sciences. Fellows will also attend at least one annual meeting at the HHMI headquarters to meet other HHMI researchers and receive professional development mentoring as they... Read More

  • Sandra Gonzalez's summer research gains attention

    November 14, 2012

    Sandra Gonzalez, a 2010 graduate of South Mountain High School in Phoenix, spent the summer after her freshman year as a biomedical engineering major at the University of Arizona getting hands-on research experience at Arizona State University.  Her research accomplshments have resulted in a scientific publicaiton that will soon appear in the Biosensors journal.  During her summer research experience, Sandra collaborated with Jeffrey La Belle, an assistant professor in the School of Biological and Health Systems Engineering at Arizona State University.  Together, they determined the... Read More

  • Dr. Chris Flask visits CAMEL

    November 12, 2012

    Dr. Chris Flask, Assistant Professor of Radiology, Biomedical Engineering, and Pediatrics at Case Western Reserve University in Cleveland, OH, visited the CAMEL and the University of Arizona on Nov 11-12, 2012. Dr. Flask presented a seminar to the Biomedical Engineering Graduate Interdisciplinary Program, titled "Quantitative MRI for Early-Stage Assessment of Lung Disease in Cystic Fibrosis". Dr. Flask also participated in two roundtables that discussed the technical development of clinical MRI protocols and the strategic approach to clinical MRI trials. These roundtables were a useful... Read More

  • CAMEL research highlighted on the 'Cancer Fighters' radio show

    November 4, 2012

    Dr. Marty Pagel joined Dave Sitton, host of the 'Cancer Fighters' show on Tucson radio station KQTH-FM on Sunday, Nov. 4, 2012. Marty and Dave discussed the recent developments of acidoCEST MRI research, including the translation of our research methods to a clinical MRI scanner for upcoming clinical feasibility studies. The future of imaing and personalized medicine were also discussed.  

  • Marty Pagel is appointed as an Arizona Engineering Faculty Fellow

    November 1, 2012

    The College of Engineering recognizes engineering faculty members who have made extra efforts to fulfill the mission of engineering research, teaching, and leadership at the University of Arizona. Dr. Marty Pagel has been appointed as an Arizona Engineering Faculty Fellow in 2012-2015 to recognize Marty's contributions to this mission. Dr. Pagel expressed his gratitude for this recognition during a 5-minute celebration in the CAMEL offices, and then he suggested that we all get back to our research work.

  • Marty Pagel is appointed as vice-chair of the WMIC program committee

    October 24, 2012

    The World Molecular Imaging Congress meeting attracts a variety of researchers in the imaging and biological sciences research fields. The next meeting will be held on September 18-21, 2013, in Savannah GA.  Dr. Marty Pagel has volunteered to be the vice-chair of the WMIC program committee, and he will assist Dr. Jason Lewis, the chair of the program committee to arrange for an outstanding meeting. In particular, Dr. Pagel has strong interests in improving the inteagration of industry research into the meeting, and further developing information technology resources in novel ways to... Read More

  • Dr. Mark Woods visits CAMEL

    October 8, 2012

    Dr. Mark Woods, Assistant Professor of Chemistry at Portland State University and the Oregon Health & Sciences University in Portand, OR, visited CAMEL on Oct 8-9, 2012.  Dr. Woods presented a seminar in the Department of Chemistry and Biochemistry, titled " Understanding Molecular Structure in Terms of Dynamics:  Implications for Molecular Imaging by MRI".  He also presented a seminar to the Cancer Imaging Program, titled "Is Gadolinium suitable for the molecular imaging of cancer?".  A highlight of Dr. Woods' visit was a dinner with members of the CAMEL group, and extensive... Read More

  • Dina Hingorani receives a travel award

    October 4, 2012

    The OctoberCEST meeting attracts the top researchers in the CEST MRI research field from the United States and europe.  Ms. Dina Hingorani has received a travel award from the OctoberCEST organizing committee to support her travel to this summit meeting.  In addition, Dina has been invited to visit the Johns Hopkins University in Baltimore, MD, as part of her travel to the meeting in Annapolis, MD.  This travel is very timely for Dina, because her research is poised to start in vivo CEST MRI studies, which is a primary topic of this meeting and the research conducted at JHU.  Dina and the... Read More

  • Iman Daryaei completes written cume exams

    September 19, 2012

    The Department of Chemistry and Biochemistry requires the completion of a series of written cume exams as part of earning a Ph.D. degree.  Mr. Iman Daryaei has recently completed this important milestone.  CAMEL would like to congratulate Iman, especially because this achievement will provide him with more time to spend in the CAMEL laboratory.

  • Liu Qi Chen receives the 2012 Anne Rita Monahan Foundation Scholarship

    September 11, 2012

    The Anne Rita Monahan Foundation is dedicated to educating and raising awareness of these signs and symptoms so that early detection will increase and instances of misdiagnosis will decrease. The Foundation also raises finances to help fund the discovery of an effective, reliable screening tool that will help detect this type of cancer early and give women the best opportunity for full remission. To fulfill this mission, The ARM Foundation will support Liu Qi Chen's  research that uses acidoCEST MRI to monitor tumor acidosis in ovarian cancer.  Liu Qi will receive her scholarship at the... Read More

  • Marty Pagel and Christy Howison establish SAMIS

    September 1, 2012

    The Small Animal Medical Imaging Services has crecently been created at the University of Arizona.  This new service group will manage four imaging scanners for in vivo, pre-clinical studies, including a MRI scanner, an Ultrasound imaging scanner, a micro-CT/X-ray scanner, and a Bioluminescence-Fluorescence Imaging scanner.  Dr. Party Pagel has been appointed as the Director of SAMIS, and will develop new scientific applications, provide training, and promote the use of SAMIS resources.  Ms. Christine Howison has been appointed as the Manager of SAMIS, and will support the daily operation... Read More

  • Liu Qi Chen and Dina Hingorani are invited to give oral presentations at OctoberCEST

    August 24, 2012

    The OctoberCEST meeting attracts researchers from across the world who are developing CEST MRI, an emerging technique for molecular imaging during pre-clinical and clinical studies.  Ms. Liu Qi Chen and Ms. Dina Hingorani will present their research at this summit meeting.  The organizers of the OctoberCEST meeting have selected Liu Qi and Dina to each present their work as an oral presentation.  Dina will present "An Enzyme-Responsive PARACEST MRI Contrast Agent that "Turns On" After Catalysis", and Liu Qi will present "Measuring extracellular pH within in vivo Tumors using AcidoCEST MRI... Read More

  • CAMEL receives grant award from the Better than Ever Program

    August 4, 2012

    The Better Than Ever Program in the University of Arizona Cancer Center is designed to encourage participants to make exercise a regular part of life, and work to prevent cancer.  The BTE raises funds by hosting exercise activities, and these funds support cancer research at the University of Arizona.  The BTE has awarded a research grant to the CAMEL for "Measuring tumor acidity in ovarian cancer patients using non-invasive CEST MRI".  This grant will translate CAMEL's acidoCEST MRI protocol to a clinical MRI scanner, and demonstrate the feasibility of assessing tumor acidosis in cancer... Read More

  • Dina Hingorani receives travel grant award from the GPSC

    July 13, 2012

    The Graduate and Professional Student Council of the University of Arizona has awarded a travel grant to Ms. Dina Hingorani.  This travel award will support Dina's travel and attendance at the OctoberCEST meeting, October 15-17, 2012, in Annapolis, MD.  This meeting attracts researchers at the forefront of CEST MRI research.  Dina will present her research concerning "An Enzyme-Responsive PARACEST MRI Contrast Agent that "Turns On" After Catalysis" at the meeting.  The opportunity to exchange information about CEST MRI protocols, clinical translation, and contrast agents will be an... Read More

  • CAMEL receives a $3M grant

    July 1, 2012

    The National Cancer Institute has awarded $3M to the CAMEL to continue our pioneering efforts that detect enzyme activiites using in vivo CEST MRI.  This proposal will develop CEST agents and improve CEST MRI methods that detect enzyme activities in pre-clinical cancer models. This proposal received a score of 17 that qualified for the 2nd percentile in the February 2012 review cycle.


  • Marty Pagel is appointed as an instructor for the NCI Cancer Research Imaging Camp

    June 24, 2012

    The National Cancer Institute organizes an annual Cancer Research Imaging Camp that provides experience with a wide range of imaging modalities, including advanced optical imaging, MRI, PET, SPECT, CT, and ultrasound imaging.  The 2012 Cancer Research Imaging Camp will be held on June 24-29, 2012, at Vanderbilt University in Nashville TN.  Dr. Marty Pagel will participate in the Cancer Research Imaging Camp as an instructor, and will discuss the "Advantages and disadvantages of Multi-Modal Imaging".  Dr. Pagel will be available throughout the week to interact with camp participants.  Dr.... Read More

  • Liu Qi Chen is awarded a TRIF imaging Fellowship

    June 22, 2012

    The TRIF Imaging Fellowship progam promotes the training of biomedical imaging researchers at the University of Arizona.  This program includes a dynamic series of meetings that promotes the interaction between student researchers.  Liu Qi Chen has been awarded a TRIF imaging fellowship for the 2012-2013 academic year and will participate in TRIF imaging events with other Fellows.

  • Dr. Arvind Pathak visits CAMEL

    June 4, 2012

    Dr. Arvind Pathak, Assisstant Professor of Radiology at Johns Hopkins University, visited CAMEL on June 4, 2012.  Dr. PAthak presented a seminar to the Cardiovascular group in the BME Graduate Interdisciplinary Program and the Cancer Imaging Program, titled " New Methods for Visualizing Tumor Blood Vessels and their Applications ".  A highlight of Dr. Pathak's visit was a CAMEL group luncheon, during which the group discussed a variety of research studies with Dr. Pathak.  In particular, JJ Jeffery and Dr. PAthak developed plans for a research colalboration that will use micro-CT to image... Read More

  • CAMEL in the Media Spotlight

    May 12, 2012

    CAMEL has recently received attention from medial sources, including newspapers, TV, radio, and internet sources, regarding our development of acidoCEST MRI.  This novel imaging method can measure the acid content in tumors in pre-clinical cancer models, and is being translated to the clinic to assess cancer patients.  Tumor acidosis can cause chemoresistance to some common small molecule therapies, so that knowing the acid level in a tumor can aid in selecting the best chemotherapy for a patient.  Furthermore, the use of baking soda as a cancer treatment is highly controversial, and our... Read More

  • Julio Cardenas earns his Ph.D. degree

    April 28, 2012

    Dr. Julio Cardenas has completed his research dissertation and fulfilled all of his requirements to earn his Ph.D. degree in Chemistry from the University of Arizona.  Julio began his graduate studies at the university of Arizona in 2007, when he joined the research program led by Dr. Bob Gillies.  When Dr. Gillies moved from the University of Arizona in 2008, CAMEL had the opportunity to recruit Julio to join our research group.  Julio initially investigated the application of standard Dynamic Contrast Enhancement MRI methods to evaluate early response to hypoxia-activated chemotherapy. ... Read More

  • CAMEL awarded $2M grant

    April 1, 2012

    The National Cancer Institute of the NIH has awarded a $2M grant to the CAMEL.  These funds will be used to continue our research that develops and applies acidoCEST MRI to measure tumor acidosis. This proposal received a score of 21 that qualified for the 5th percentile of scores during the October 2011 NIH review cycle.